Interventions to prevent hypothermia in extremely preterm low-weight infants undergoing cardiac catheterisation

BACKGROUND: In January 2019, a new device called the Amplatzer Piccolo Occluder was approved by the US Food and Drug Administration for percutaneous closure of patent ductus arteriosus in infants weighing more than 700 g and of postnatal age more than 3 days. Premature low-weight infants are predisp...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhalabi, Eliane, Zestos, Maria, Kobayashi, Daisuke, Mckelvey, George M, Taylor, Rachel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Quality Education Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486285/
https://www.ncbi.nlm.nih.gov/pubmed/36122994
http://dx.doi.org/10.1136/bmjoq-2021-001773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486285/
https://www.ncbi.nlm.nih.gov/pubmed/36122994
http://dx.doi.org/10.1136/bmjoq-2021-001773

Ejemplares similares